GeneSight

GeneSight

The GeneSight test analyzes how your genes may affect outcomes with certain psychiatric medications.

Founded 2006 201-500 employees Series D Total: $99.72M Biotechnology, Health Care +1

GeneSight is a biotechnology and healthcare startup founded in 2006. The company's slogan, "The GeneSight test analyzes how your genes may affect outcomes with certain psychiatric medications." accurately captures its core offering. GeneSight offers a pharmacogenomic test that examines clinically significant genetic variations in a patient’s DNA to provide clinicians with valuable insights. Their test results offer information to clinicians about medication efficacy, required dosage adjustments, and potential side effects based on a patient’s genetic makeup. Notably, the test can be taken either at home or at a clinician’s office, offering convenience and flexibility to patients. In its Series D funding round in December 2015, GeneSight secured a substantial $15.00M investment from a group of notable investors, including Claremont Creek Ventures, Four Rivers Group, Sequoia Capital, and Alafi Capital. This investment reflects confidence in GeneSight's potential to make a significant impact in the pharmaceutical and healthcare industries.

Funding Stage	Amount	Investors	Lead Investors	Date
Series D	$15.00M	4	Claremont Creek Ventures, Four Rivers Group +2	21 Dec 2015
Series D	$37.39M	7	CincyTech, Allos Ventures +5	23 Dec 2014
Debt Financing	$25.00M	5	Allos Ventures, Claremont Creek Ventures +3	21 May 2014
Series C	$12.50M	5	CincyTech, Allos Ventures +3	30 May 2012
Debt Financing	$8.00M	2	Allos Ventures, Silicon Valley Bank	31 Jan 2012
Venture Round	$1.58M	-		07 Jul 2010
Seed Round	$250.00K	1	CincyTech	24 Dec 2007

Funding Stage

Amount

Investors

Lead Investors

Date

Series D

$15.00M

Claremont Creek Ventures, Four Rivers Group +2

21 Dec 2015

Series D

$37.39M

CincyTech, Allos Ventures +5

23 Dec 2014

Debt Financing

$25.00M

Allos Ventures, Claremont Creek Ventures +3

21 May 2014

Series C

$12.50M

CincyTech, Allos Ventures +3

30 May 2012

Debt Financing

$8.00M

Allos Ventures, Silicon Valley Bank

31 Jan 2012

Venture Round

$1.58M

07 Jul 2010

Seed Round

$250.00K

CincyTech

24 Dec 2007

FAQ About GeneSight

The GeneSight test analyzes how your genes may affect outcomes with certain psychiatric medications.

GeneSight was founded in 2006.

GeneSight operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on pharmacogenomic testing, personalized medicine, GeneSight test and clinical genetics.

GeneSight has approximately 201-500 employees.

GeneSight has completed 7 funding rounds, raising a total of $99.72M. The latest funding stage is Series D.

Top alternatives and competitors to GeneSight include 广州嘉检医学检测有限公司, Ariel Precision Medicine, NalaGenetics, Psycheceutical, Mesh Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

GeneSight and 广州嘉检医学检测有限公司 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About GeneSight

Funding Rounds & Investors (7)

GeneSight Alternatives & Competitors

FAQ About GeneSight